Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Patients With Chronic Primary ITP”

10 trials

Showing 10 of 10 results

Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Early research (Phase 1)UnknownNCT06062680
What this trial is testing

Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects

Who this might be right for
Adult Patients With Chronic Primary ITPAdult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
Jiangsu HengRui Medicine Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT05621330
What this trial is testing

Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Qilu Pharmaceutical Co., Ltd. 216
Large-scale testing (Phase 3)UnknownNCT06004856
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd. 195
Early research (Phase 1)UnknownNCT06346925
What this trial is testing

Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects.

Who this might be right for
Adult Patients With Chronic Primary ITPAdult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
Jiangsu HengRui Medicine Co., Ltd. 18
Not applicableStudy completedNCT06665308
What this trial is testing

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Immune ThrombocytopeniaPrimary Immune ThrombocytopeniaAdult Immune Thrombocytopenia
Sanofi 97
Large-scale testing (Phase 3)Looking for participantsNCT05338190
What this trial is testing

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Assistance Publique - Hôpitaux de Paris 132
Testing effectiveness (Phase 2)Study completedNCT04278924
What this trial is testing

TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Takeda 41
Testing effectiveness (Phase 2)UnknownNCT05232149
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Beijing InnoCare Pharma Tech Co., Ltd. 30
Large-scale testing (Phase 3)Looking for participantsNCT07059000
What this trial is testing

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Chronic Primary Immune Thrombocytopenia (ITP)
Kedrion S.p.A. 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation